Evidence map›Paper›PMID 40109098›Full record

ArticleAdvanced healthcare materials2025

Functionalized Cerium Oxide Nanoparticles Enhance Penetration into Melanoma Spheroids In Vivo through Angiogenesis.

Lu Fu, Joel M Yong, Robyn Yeh, Florence Bartlett, John M Whitelock, Megan S Lord

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lu FuGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Joel M YongGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Robyn YehGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Florence BartlettKatherina Gaus Light Microscopy Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, 2052, Australia.
John M WhitelockGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Megan S LordGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID 0000-0002-0506-9811

Funding

Australian Government Research Training Program ScholarshipAustralian Research Council FT220100092Australian Research Council LP140101056
6 · The paper itself

Abstract

Angiogenesis is a crucial step in tumor progression, including melanoma, making anti-angiogenic strategies a widely explored treatment approach. However, both innate and acquired resistance to these therapies suggest that this approach may need re-evaluation. Nanoparticles have gained attention for their potential to enhance drug delivery and retention within tumors via the bloodstream. However, the in vitro screening of nanoparticles is limited by the inability of preclinical models to replicate the complex tumor microenvironment, especially the blood supply. Here, it is demonstrated that melanoma cells embedded in Matrigel spheroids can engraft in and be vascularized by the chorioallantoic membrane (CAM) of fertilized chicken eggs. This model allows for the assessment of nanoparticle toxicity and accumulation in tumor spheroids, as well as functional effects such as angiogenesis. Cerium oxide nanoparticles (nanoceria) and their surface functionalized derivatives are widely explored for biomedical applications due to their ability to modulate oxidative stress and angiogenesis. Here, it is observed that heparin functionalized nanoceria penetrate melanoma spheroids in the CAM and promote spheroid vascularization to a greater extent than nanoceria alone. This study aids in the development of preclinical cancer models for nanoparticle screening and provides new insight into the interplay between nanoparticle surface coatings and biological effects.

Indexed as

CeriumMelanomaNanoparticlesNeovascularization, PathologicSpheroids, CellularAngiogenesisAnimalsCell Line, TumorChick EmbryoChorioallantoic MembraneHumansceric oxideCeriumangiogenesiscerium oxidemelanomananoparticletumor spheroid

Identifiers

PMID40109098
PMCPMC12057615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.